Research Funding

Funding Opportunity Announcements

Browse below for Data Science Funding Opportunity Announcements.

This page last reviewed on September 14, 2018

Feed last updated: June 25 2019 9:56 am
Title FOA Number Organization Release Date Expiration Date Purpose Search Terms
The KUH Predoctoral to Postdoctoral Fellow Transition Award (F99/K00 Clinical Trial Not Allowed)

RFA-DK-18-024

NIDDK

Jan 28 2019

Nov 21 2019

The purpose of the KUH/NIDDK Predoctoral to Postdoctoral Fellow Transition Award (F99/K00) is to recruit exceptional graduate students who are recognized by their institutions for their high potential and to incentivize them to pursue a Kidney, Urologic or Hematologic (K, U, or H) postdoctoral position that ultimately positions them to become independent K, U, or H researchers. This two-phase award will facilitate completion of the doctoral dissertation and stablize the transition of highly talented Ph.D candidates from a variety of fields, including, but not limited to, engineering, statistics, data science, imaging, biochemistry and genetics into strong postdoctoral appointments that are focused on K, U or H research. It is anticipated that successful completion of this phased award will make the individual highly competitive for a subsequent NIDDK award (e.g., K99/R00, R01). Opportunities for career development activities relevant to their long-term career goals of becoming independent researchers will be provided. Graduate students who are already involved in K, U, or H research are encouraged to apply for the NIDDK F31 (PA-18-671).
This Funding Opportunity Announcement (FOA) does not allow applicants to propose to lead an independent clinical trial, but does allow applicants to propose research experience in a clinical trial led by a sponsor or co-sponsor

data science
The Electronic Medical Records and Genomics (eMERGE): Genomic Risk Assessment and Management Network - Enhanced Diversity Clinical Sites (U01 Clinical

RFA-HG-19-014

NHGRI

May 23 2019

Aug 03 2019

This Funding Opportunity Announcement (FOA) invites applications to participate in the Electronic Medical Records and Genomics (eMERGE) Genomic Risk Assessment and Management Network. This network will continue to use biorepositories linked with electronic medical records (EMRs) for genomic research by developing, evaluating, and disseminating genomic risk assessment and management tools for clinical use. Applicants to this FOA are expected to recruit a minimum of 75% of patients who come from racial or ethnic minority populations, underserved populations, or populations who experience poorer medical outcomes. In contrast, applicants to the companion RFA-HG-19-013 are expected to recruit a minimum of 35% of such patients.

data science, informatics, common data, natural language processing
The Electronic Medical Records and Genomics (eMERGE): Genomic Risk Assessment and Management Network - Coordinating Center (U01 Clinical Trial Require

RFA-HG-19-015

NHGRI

May 23 2019

Aug 03 2019

The purpose of this funding opportunity announcement (FOA) is to continue genomic implementation research in the Electronic Medical Records and Genomics (eMERGE) Network by providing support for a Coordinating Center (CC) to provide centralized support, infrastructure, coordination, and data analysis for the program.

data science, informatics, common data, natural language processing
The Electronic Medical Records and Genomics (eMERGE): Genomic Risk Assessment and Management Network - Clinical Sites (U01 Clinical Trial Required)

RFA-HG-19-013

NHGRI

May 23 2019

Aug 03 2019

This Funding Opportunity Announcement (FOA) invites applications to participate in the Electronic Medical Records and Genomics (eMERGE) Genomic Risk Assessment and Management Network. This network will continue to use biorepositories linked with electronic medical records (EMRs) for genomic research by developing, evaluating, and disseminating genomic risk assessment and management tools for clinical use. Applicants to this FOA are expected to recruit a minimum of 35% of patients who come from racial or ethnic minority populations, underserved populations, or populations who experience poorer medical outcomes. In contrast, applicants to the companion RFA-HG-19-014 are expected to recruit a minimum of 75% of such patients.

data science, informatics, common data, natural language processing
T32 Training Program for Institutions That Promote Diversity (T32 Clinical Trial Not Allowed)

RFA-HL-19-023

NHLBI

Apr 27 2018

May 07 2021

The purpose of this funding opportunity announcement (FOA) is to enhance the participation of individuals from diverse backgrounds underrepresented in cardiovascular, pulmonary, hematologic and sleep disorders research across the career development continuum. The NHLBIs T32 Training Program for Institutions That Promote Diversity is a Ruth L. Kirschstein National Research Service Award Program intended to support training of predoctoral and health professional students and individuals in postdoctoral training institutions with an institutional mission focused on serving health disparity populations not well represented in scientific research, or institutions that have been identified by federal legislation as having an institutional mission focused on these populations, with the potential to develop meritorious training programs in cardiovascular, pulmonary, and hematologic diseases, and sleep disorders. The NHLBIs T32 Training Program for Institutions That Promote Diversity is designed to expand the capability for biomedical research by providing grant support to institutions that have developed successful programs that promote diversity, serve health disparity populations, and that offer doctoral degrees in the health professions or in health-related sciences. These institutions are uniquely positioned to engage minority and other health disparity populations in research, translation, and implementation of research advances that impact health outcomes, as well as provide health care for these populations. This Funding Opportunity Announcement (FOA) does not allow appointed Trainees to lead an independent clinical trial, but does allow them to obtain research experience in a clinical trial led by a mentor or co-mentor.

data science, big data, quantitative science, bioinformatics
Stimulating Access to Research in Residency (StARR) (R38)

RFA-HL-18-023

NHLBI

Aug 23 2017

May 13 2020

The purpose of this program is to recruit and retain outstanding, postdoctoral-level health professionals who have demonstrated potential and interest in pursuing careers as clinician-investigators. To address the growing need for this critical component of the research workforce, this funding opportunity seeks applications from institutional programs that can provide outstanding mentored research opportunities for Resident-Investigators and foster their ability to transition to individual career development research awards. The program will support institutions to provide support for up to 2 years of research conducted by Resident-Investigators in structured programs for clinician-investigators with defined program milestones.

data science, bioinformatics
Single Cell Opioid Responses in the Context of HIV (SCORCH) Program: CNS Data Generation (UM1 Clinical Trial Not Allowed)

RFA-DA-19-037

NIDA

Apr 01 2019

Oct 09 2019

To support generation of single cell datasets for one or more brain regions relevant to opioid use disorder and persistent HIV infection. If fully successful, this project will generate 1. A cellular parts list for selected NIDA-relevant brain regions, 2. Reveal how cell types within these brain regions differ from one another with respect to gene expression, 3. Reveal how cell types within these brain regions are altered by chronic opioid exposure providing potential novel therapeutic targets for opioid addiction, 4. Reveal how HIV infection in the CNS influences single cells, providing potential targets for improving HIV neurobiological sequelae, and 5. Uncover potential synergistic effects of chronic opioid exposure and HIV infection in the CNS.

data science
Short-Term Research Education Program to Increase Diversity in Health-Related Research (R25 Clinical Trial Not Allowed)

RFA-HL-19-024

NHLBI

May 01 2018

May 07 2021

The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this NHLBI R25 program is to support educational activities that enhance the diversity of the biomedical, behavioral and clinical research workforce in the mission areas of importance to NHLBI.
To accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary focus on Research Experiences

data science, big data, bioinformatics
Research Career Enhancement Award to Advance Therapy Development for Alzheimer's (K18)

PAR-17-052

NIA

Nov 07 2016

Jan 08 2020

This NIA Research Career Enhancement Award (K18) program invites applications from qualified researchers to acquire training and career development experiences that close expertise gaps in data science and in drug discovery. The goal of the program is to allow Alzheimer's Disease (AD) researchers to expand their expertise to become more effective in leading cross-disciplinary, translational, team-science projects in AD or AD-related dementias (ADRD). This award will also allow data scientists to redirect their expertise toward the study of AD and ADRD.

data science, computational, informatics
RESCINDED - Notice of Intent to Publish a Funding Opportunity Announcement for Rare Disease Cohorts in Heart, Lung, Blood and Sleep Disorders (UG3/UH3

NOT-HL-18-620

NHLBI

Apr 13 2018

N/A

Notice Intent Publish Funding Opportunity Announcement Rare Disease Cohorts Heart, Lung, Blood Sleep Disorders UG3/UH3) Notice Number: NOT-HL-18-620 Key Dates Release Date: April 13, 2018 RESCINDED) Estimated Publication Date Funding Opportunity Announcement: 12/01/2018 First Estimated Application Due Date:02/01/2019 Earliest Estimated Award Date:10/31/2019 Earliest Estimated Start Date:12/31/2019 Related Announcements None Issued National Heart, Lung, Blood Institute NHLBI) Purpose National Heart, Lung Blood Institute intends promote new initiative establish cohorts rare heart, lung, blood, and/or sleep HLBS) diseases enables multidisciplinary teams conduct natural history mechanistic studies provide evidence base future clinical trials improved diagnostics.  studies help advance fundamental insights key molecular, genomic, clinical, environmental behavioral determinants rare HLBS diseases their outcomes leading diagnostic therapeutic strategies.   NHLBI interested applications will address questions relevant the NHLBI mission, address gaps the NHLBI?s portfolio rare disease cohorts that align the Institute ' s Strategic Vision https://www.nhlbi.nih.gov/about/documents/strategic-vision). NHLBI intends to utilize UG3/UH3 activity code, bi-phasic, milestone-driven cooperative agreement. Details the planned FOA provided below. Notice being provided allow potential applicants sufficient time develop responsive proposals.  FOA expected be published October 2018 anticipated application receipt dates February 2019 February 2020. Research Initiative Details planned initiative provide opportunities efficiently advance rare disease research using genetics deep phenotyping characterize disease to identify disease sub-types; use data science methods integrate clinical patient-reported outcomes PROs) laboratory, imaging omics data understand natural history disease;  generate data differentiate patients the same morphological phenotype different genetic mutations  severity outcomes; elucidate genotype-phenotype interactions multisystem phenotyping develop reliable valid predictive tools determine will respond which treatments when intervene; to encourage innovative methods such telemedicine reach subjects rare diseases located remote locations without access a major academic medical center. goal this initiative to encourage creative innovative research; such, applications should propose studies investigating hypotheses research questions currently addressed cohorts funding the NHLBI. RFA invite applications propose cohorts are created de novo or re-establish study populations enrolling patients previously-funded cohorts, clinical trials registries. Funding Information Estimated Total Funding 1,625,000 Total Costs) Expected Number Awards 4 Estimated Award Ceiling 500,000 Direct Costs) Primary CFDA Numbers 93.837, 93.838, 93.839, 93.840, 93.233 Anticipated Eligible Organizations Public/State Controlled Institution Higher Education Private Institution Higher Education Nonprofit 501(c)(3) IRS Status than Institution Higher Education) Nonprofit without 501(c)(3) IRS Status than Institution Higher Education) Small Business For-Profit Organization than Small Business) State Government Indian/Native American Tribal Government Federally Recognized) City township governments Indian/Native American Tribally Designated Organization Native American tribal organizations than Federally recognized tribal governments) Indian/Native American Tribal Government than Federally Recognized) Regional Organization  Applications not being solicited this time.   Inquiries Please direct inquiries to: Ellen M. Werner, PhD, MA  National Heart, Lung, Blood Institute  301-435-0065  wernere@nhlbi.nih.gov 

data science

Pages

XLS